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Abstract 21 
Objectives: Health, disease and immune function are key areas of research in studies of 22 
ecology and evolution, but work on free-ranging primates has been inhibited by a lack of 23 
direct non-invasive measures of condition. Here, we evaluate the potential usefulness of 24 
non-invasive measurement of three biomarkers, the acute-phase proteins C-reactive protein 25 
(CRP) and haptoglobin, and neopterin, a byproduct of macrophage activity. 26 
Materials and Methods: We took advantage of veterinary checks on captive rhesus (24) and 27 
long-tailed (3) macaques at the German Primate Center (DPZ) to compare serum marker 28 
measures, before measuring concentrations in feces and urine, and evaluating relationships 29 
between matched serum, urine and fecal concentrations. In a second study, we monitored 30 
excretion of these markers in response to simian immunodeficiency virus (SIV) infection and 31 
surgical tissue trauma, undertaken for a separate study. 32 
Results: We found that each biomarker could be measured in each matrix. Serum and 33 
urinary concentrations of neopterin were strongly and significantly correlated, but neither 34 
haptoglobin nor CRP concentrations in excreta proxied circulating serum concentrations. 35 
Our infection study confirmed that urinary neopterin in particular is a reliable marker of 36 
viral infection in macaques, but also indicated the potential of urinary and fecal CRP and 37 
haptoglobin as indicators of inflammation. 38 
Discussion: We highlight the potential of noninvasive markers of immune function, 39 
especially of urinary neopterin, which correlates strongly with serum neopterin, and is 40 
highly responsive to infection. 41 
42 
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Introduction 43 
Health in general, and immune function in particular, are key areas of both applied and 44 
basic research in the study of ecology and evolution (Kappeler & Nunn 2015). Areas of 45 
research that include immune function as central elements include primate disease ecology 46 
(e.g. Nunn, 2006, 2012), , MHC function and its role in pathogen responsiveness 47 
(Schwensow et al., 2007) and mate choice (e.g. Schwensow et al., 2008), and the 48 
importance of environmental and social stress and its effects on health and disease (e.g. 49 
Gordis et al., 2008; Jemmott et al., 1988; Cavigelli and Chaudry 2012). Though the 50 
assessment of immune function and activation is of great relevance for many studies, it has 51 
proven difficult to measure in studies of large-bodied free-ranging mammals, where it is 52 
often not possible to trap individuals for the collection of blood. 53 
In recent decades, the non-invasive measurement of physiological parameters has 54 
revolutionized studies of captive and free-ranging mammals, allowing unprecedented 55 
investigation of the proximate factors mediating behavioral and life history variation. Such 56 
techniques are particularly commonly used in larger-bodied animals such as elephants and 57 
non-human primates. Established examples include the measurement of steroid hormones 58 
(see Wheaton et al. 2011, for a review) as well as proteins and peptides, such as 59 
concentrations of urinary C-peptide of insulin (Sherry and Ellison, 2007). One element of 60 
physiology that is usually missing from field studies is a direct measure of infection or 61 
immune activation. Physical health has instead been commonly assessed by using visual 62 
estimates of physical condition, for example the estimation of body fat (e.g. Berman and 63 
Schwarz, 1988; Koenig et al., 1997), and wounds (e.g. Archie et al., 2012), or by the 64 
quantification of fecal parasite load (e.g. Gillespie et al., 2005; Gillespie and Chapman, 2006; 65 
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Weyher et al., 2006). Although useful, these measures are crude and only indirectly (if at all) 66 
reflect the immune status of an individual, and measures such as inter-individual differences 67 
in macroparasite loads measured at individual timepoints can be particularly hard to 68 
interpret and misleading with respect to aspects of immunity (e.g. Habig and Archie 2015). 69 
As such, new non-invasive markers of immune activity and health would be highly valuable. 70 
In the present study, we investigate several non-invasive (urinary and fecal) markers 71 
of immune responses that might potentially be useful to assess individual health in field 72 
studies of non-human primates. We focus specifically on macaques (where much work on 73 
non-invasive physiological assessment has been undertaken, e.g. Engelhardt et al., 2004, 74 
2005; Brauch et al., 2008; Heistermann et al., 2006; Girard-Buttoz et al., 2009, 2011; Ostner 75 
et al., 2008; Higham et al., 2011a, 2013). Potential markers of the inflammatory immune 76 
response include cytokines and chemokines (e.g. urinary IL-8, IL-6; serum values of such 77 
cytokines have recently been published from free-ranging rhesus macaques, Hoffman et al., 78 
2011), acute phase proteins, and surrogate markers of immune responses. We chose three 79 
markers for further investigation. The first two of these are the acute phase proteins C-80 
reactive protein (CRP) and haptoglobin, which are secreted by the liver in response to most 81 
forms of tissue damage, infection, inflammation and neoplasia. They are therefore useful 82 
nonspecific biochemical inflammatory markers (Pepys and Hirschfield, 2003; Gabay and 83 
Kushner, 1999). An acute phase protein is defined as a protein that responds to 84 
inflammation with a change in concentration of at least 25% (Gabay and Kushner, 1999), but 85 
responses are usually much more substantial. In humans for example, CRP can increase in 86 
response to inflammation by more than 1000% (Gabay and Kushner, 1999; Pepys and 87 
Hirschfield, 2003) and in dogs CRP increases markedly (up to 45 fold) in response to surgery 88 
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(Yamamoto et al., 1993; Michelsen et al., 2012). Increased expression of such acute phase 89 
proteins is often associated with long-term chronic health consequences (e.g. CRP and 90 
cardiovascular disease, Ridker et al. 2000). The third biomarker we assessed was neopterin, 91 
which is a byproduct of macrophage activity upon stimulation by γ-interferon secretion from 92 
activated T-lymphocytes, and is regarded as an early marker of the Th1 response of cell-93 
mediated immunity (Widner et al., 2000). Apart from the general availability of assays to 94 
measure these analytes in biological samples of primates, the fact that they are broadly 95 
implicated in many immune responses and are not related to any specific infection makes 96 
them highly suitable for primate field studies, where researchers will very rarely know the 97 
precise infection or disease that the animals are suffering from. 98 
In addition, these markers are commonly measured in blood and used in studies of 99 
infection and disease in humans (neopterin, Plata-Nazar et al,. 2010, Rho et al., 2011; CRP, 100 
Rudzite et al. 2003), but also in macaques (e.g. neopterin, Heyes et al., 1991; CRP, Hart et 101 
al., 1998; Jinbo et al., 1998, 1999; Klingstroem et al., 2002), and in other mammals including 102 
mice (CRP; Huntoon et al., 2008), dogs (CRP; Yamamoto et al., 1993), pigs (CRP; Breineková 103 
et al., 2007) and other livestock (haptoglobin and CRP, Peterson et al., 2004). They have also 104 
been measured in excretory products (urine and feces) of humans and have been utilized as 105 
non-invasive markers of infection and immune activation, including in studies of intestinal 106 
infection, inflammation and macrophage activity (fecal neopterin, Ledjeff et al., 2001; 107 
Campbell et al., 2004; urinary and fecal neopterin, Husain et al., 2013), intestinal health 108 
(fecal haptoglobin; Matsumoto et al., 2001), general immune status (urinary neopterin, 109 
Baydar et al., 2011) and gynecological cancer (urinary neopterin, Melichar et al., 2006). In 110 
such cases they may not be measured because excreta concentrations indicate systemic 111 
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infectious status, but because they are indicative of more specific local infections in tissues 112 
related to urinary or fecal excretion pathways, such as the kidneys and the gut. Finally, some 113 
have been investigated and/or utilized as non-invasive markers of immune function in non-114 
human animals, including primates. For example, urinary neopterin has been used to 115 
monitor simian immunodeficiency virus (SIV) infection in rhesus macaques (Fendrich et al., 116 
1989; Stahl-Hennig et al., 2002), while urinary neopterin (Amann et al., 2001) and salivary 117 
haptoglobin and CRP (Gómez-Laguna et al., 2010) have been used to document immune 118 
activation and monitor herd health in pigs. 119 
To assess the validity of measurements of these immune markers in non-invasive 120 
samples (urine, feces) of macaques, we took two approaches. In study 1, we took advantage 121 
of the regular health monitoring that is undertaken on macaques at the German Primate 122 
Center to obtain temporally-matched blood, fecal and urine samples from non-infected 123 
individuals. Using these samples, we assessed relationships between serum and urinary, and 124 
serum and fecal, concentrations of each marker to determine whether these correlate, and 125 
hence whether the non-invasive measures might serve as proxy for the serum measures, 126 
and also whether both non-invasive measures might be equally suitable proxies. 127 
In study 2, we took advantage of a SIV infection experiment in combination with 128 
medical interventions and surgery in six rhesus macaques (carried out as part of a separate 129 
study by the German Primate Center´s  Unit of Infection Models), to assess the response 130 
patterns of the three immune markers in urine and feces to infection and surgery. In 131 
contrast to the cross-sectional correlative data collected from healthy animals, this 132 
experimental approach should provide more direct information on the potential usefulness 133 
of each marker in each matrix for assessing macaque immune activation and inflammatory 134 
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responses. Collectively, our analyses represent an initial assessment of the feasibility of 135 
measuring these markers in primate excreta, provide baseline data for levels of these 136 
markers in healthy animals, and assess their usefulness in reflecting immune activation and 137 
inflammation in response to an experimentally induced acute infection and surgical tissue 138 
trauma. 139 
140 
Methods 141 
Research Ethics 142 
All samples were collected during health checks of the macaque colony (e.g. annual health 143 
check) or when animals were already immobilized for other purposes. Samples were 144 
collected according to the ASAB/ABS guidelines on the ethical treatment of animals, and the 145 
International Primatological Society guidelines on the ethical treatment of primates in 146 
research. Urine and fecal samples collected from the SIV-infected animals were all collected 147 
non-invasively without animal handling. 148 
149 
Study animals and sample collection 150 
Study 1: Measurement of immune markers in healthy macaques 151 
This study was conducted between Aug 2011 and Mar 2012 on 24 rhesus macaques (18 152 
males, 6 non-pregnant females) and 3 male long-tailed macaques, which were housed at the 153 
German Primate Centre, Göttingen, Germany. Animals ranged in age between 3 and 11 154 
years, with an average age (± SEM) of 7.4 ±0.5 years. Average body weight was 7.6 ±0.4 kg 155 
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(males: 6.7±0.5 kg; females: 10.3 ±0.5 kg; overall range: 4.6-11.7 kg). Individuals were 156 
housed either as same-sex pairs or in small same-sex groups in indoor cages and were fed 157 
twice a day with commercial monkey chow supplemented with fruits and vegetables. Water 158 
was available ad libitum. 159 
From each study animal, matching urine, fecal and blood samples were collected 160 
between 6.00 and 10.00 am for the measurement of neopterin (NEO), C-reactive protein 161 
(CRP), and haptoglobin (HPT) concentrations as well as for the determination of 162 
hematological parameters. At the time of sample collection, all animals were in good body 163 
condition (mean BMI: 27.4±1.1; range 20.8-45.0), visually healthy and showed no obvious 164 
signs of any disease, except for one male who exhibited diarrhea. Veterinarians made the 165 
decision to euthanize this animal 3 weeks after sample collection due to severe gut 166 
problems and substantial weight loss. For urine and fecal sample collection, a study animal 167 
was usually separated from its group members in the early morning (6.00 - 6.30 am) and 168 
samples were collected upon urination and defecation on a plastic mat placed underneath 169 
the cage. Only urine and fecal samples not obviously cross-contaminated with each other 170 
were collected. Urine samples were immediately protected from light. For blood collection, 171 
animals were subsequently (between 8.30 and 10.00 a.m. the same day) anesthetized with 172 
an intra-muscular injection of ketamine hydrochloride (10mg/kg; Ketavet®). A blood sample 173 
(4-8 ml) was drawn from the femoral vein of the animal  and collected into a heparinized 174 
tube. All samples were kept cold (4°-7°C) upon collection and transferred to the 175 
endocrinology laboratory within 4 hours of collection for further processing. Blood samples 176 
were centrifuged at 1800 g for 10 min and plasma subsequently recovered and aliquoted. 177 
Fresh fecal samples were well mixed using a spatula and from each sample two aliquots of 178 
Page 8 of 38
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
9 
0.1 to 0.2 g were accurately weighted into 15 ml polypropylene tubes for future extraction. 179 
Urine samples were also aliquoted, and all aliquots of each sample type were then stored 180 
frozen at -20°C until analysis. 181 
182 
Study 2: Measurement of immune markers in response to SIV-infection 183 
This study was undertaken between February and April 2014 on 6 rhesus macaques (3 184 
males, 3 females) which were infected with SIV as part of a separate study undertaken by 185 
the German Primate Center’s Unit of Infection Models. Animals ranged in age between 4 186 
and 5 years, with an average age (± SEM) of 4.6 ±0.2 years. Average body weight was 187 
5.6±0.3 kg (males: 5.7 ±0.2 kg; females: 5.5 ±0.6 kg; overall range: 4.4-6.4 kg). Body weight 188 
of individuals fluctuated by less than 1% during the study period. The study was approved 189 
by the Lower Saxony State Office for Consumer Protection and Food Safety and performed 190 
with the project license 33.9-42502-04-12/0758-08. For infection, which required a deeper 191 
anesthesia, animals received a mixture of ketamine, xylazine and atropine. Each monkey 192 
was inoculated with 50% 1000 tissue culture infectious doses of the virus intravenously. The 193 
infection was confirmed by determining plasma viral RNA load. 194 
During the experiment animals were subject to minor medical interventions, such as bone 195 
marrow aspiration and colon biopsies (all under anesthesia). They also underwent (together 196 
with bone marrow aspiration and colon biopsy) one surgical removal of peripheral lymph 197 
nodes two weeks post infection. In particular the latter likely involved surgical tissue trauma 198 
which is known to result in an acute phase protein response (e.g. Yamamoto et al. 1993; 199 
Michelsen et al. 2012).  This situation thus provided a useful test case for assessing the 200 
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10 
potential of the urinary and fecal CRP and haptoglobin measurements in indicating 201 
inflammatory processes. 202 
Urine and fecal samples for immune marker measurements were collected once 203 
weekly for 4 weeks prior to virus inoculation and at least 3 times a week for 31 days 204 
thereafter. Samples were collected, processed and stored as described for study 1. 205 
206 
Sample measurement for immune marker analysis 207 
Plasma, urine and fecal samples were analyzed for concentrations of NEO, CRP and HPT 208 
using commercial enzyme-immunoassay (ELISA) kits (see below). While plasma and urine 209 
samples were taken unextracted to assay following appropriate dilution with assay buffer 210 
(NEO) or sample diluent (CRP, HPT) provided with the respective kits, fecal samples had to 211 
be extracted prior to analysis. For NEO, the extraction followed the procedure described by 212 
Campbell et al. (2004) with small modifications. Specifically, fecal aliquots were thawed at 213 
room temperature and one ml of 0.9% saline was added to all samples which were then 214 
agitated for 10 min on a multi-tube vortexer. Samples were then centrifuged at 1800 g for 215 
15 min and the supernatant recovered for analysis. Extraction of the two acute phase 216 
proteins was carried out according to a protocol provided by Immundiagnostic AG, 217 
Bensheim, Germany. Specifically, defrosted fecal samples were mixed with 1 ml of CRP 218 
washing buffer and agitated for 10 min on a multi-tube vortexer. Samples were then 219 
centrifuged at 1800 g for 15 min, the supernatant transferred into a 1.5ml polypropylene 220 
tube, and centrifuged at 7500 g rpm for 5 min. 100 µl of the resulting supernatant was then 221 
taken to CRP and HPT analysis. In order to compensate for the potential effect of differences 222 
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in water content of fecal samples on immune marker concentrations, following extraction 223 
fecal dry weights for each sample were determined by drying samples in an oven at 50°C to 224 
a constant weight. Fecal concentrations of each marker are expressed as ng per g of dried 225 
feces (Campbell et al. 2004). Concentrations of urinary analytes were indexed by urinary 226 
creatinine, measured as described (Bahr et al. 2000). 227 
228 
Laboratory Analyses 229 
NEO concentrations were determined using a human ELISA kit (Art. No. RE59321) from IBL 230 
International GmbH, Hamburg, Germany. The assay was performed according to the 231 
manufacturer´s instructions. While plasma and fecal extracts were assayed undiluted, urine 232 
samples were diluted 1:10 – 1:100 with assay buffer to bring sample concentrations into the 233 
working range of the assay. For Study 2, prior to ELISA analysis (see above) urine samples 234 
were initially measured via HPLC (Schroecksnadel et al., 2006) (data not shown). This 235 
enabled us to reduce analytical costs by restricting our ELISA analysis to the most important 236 
samples as indicated by the HPLC data. NEO measures generated by ELISA vs HPLC were 237 
strongly and highly significantly correlated with an r-value of 0.96 (n=84, p<0.001). 238 
Detection limit of the ELISA assay was 0.18 ng/ml. Inter-assay coefficients of variation, 239 
determined by repeated measurement of high and low value quality controls in each assay 240 
and across studies, were 12.0% and 6.6%, respectively. 241 
All CRP and HPT measurements were carried out using ELISA kits for monkey CRP 242 
(Cat. No. 2210-4) and monkey haptoglobin (Cat. No. 2410-5) from Life Diagnostics, Inc., 243 
West Chester, USA.  Both assays were performed according to the manufacturer´s 244 
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instructions. For both assays, fecal extracts were taken undiluted to assay, except for two 245 
samples which were diluted 1:10 for HPT. While urine samples were usually diluted 1:2 for 246 
both assays, plasma samples were normally diluted 1:1,000 for CRP measurements and 247 
1:100,000 for HPT determinations. Detection limits of the assays were 1.17 ng/ml for CRP 248 
and 1.56 ng/ml for HPT and inter-assay coefficients of variation of a high and low 249 
concentrated quality control were 9.6% and 10.3% for CRP and 8.4% and 9.6% for HPT. All 250 
measures of intra- and inter-assay variation were within accepted norms. 251 
252 
Statistical Analyses 253 
To assess potential sex or age effects on immune marker concentrations we examined 254 
serum levels of the three immune markers in the Study 1 animals. One animal that was 255 
known to be sick (n=1) was excluded from this analysis in order to remove any effects of this 256 
individual on age or sex differences. Residual values of parametric analyses did not meet 257 
model assumptions even if dependent variables were log-transformed, as determined by 258 
inspection of residual QQ plots. Visual inspection reveals the distributions of several 259 
variables to be non-normally distributed, but as expected for markers that show huge 260 
responsiveness to infection/inflammation, exhibiting numerous similar lower values but 261 
with occasional much higher values. We undertook univariate general linear model (GLM) 262 
analyses on each serum marker separately (fixed factor, sex; covariate, age) so that both 263 
variables could be assessed in the same model. However, we also tested each variable 264 
separately using non-parametric statistics (Mann Whitney U test, Spearman’s rank 265 
correlation), and present these results in addition where they differ from those of the 266 
parametric statistics. 267 
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We used bivariate correlations to assess serum to urinary and serum to fecal 268 
relationships for each marker. Variables were not normally distributed, and this was still the 269 
case even after log-transformation. We therefore undertook non-parametric Spearman’s 270 
rank correlations throughout. Sample sizes sometimes change slightly between analyses as 271 
in one or two cases there was insufficient urine volume to measure all variables. Tests were 272 
one-tailed as we clearly predicted a positive correlation between these variables. 273 
In order to present descriptive statistics for the magnitude of biomarker responses 274 
to SIV infection (NEO) and surgical trauma (CRP, HPT) in Study 2 animals, we determined for 275 
both urine and feces the peak-to-baseline ratios of each marker (for males and females 276 
separately, and combined). For calculating baseline values we took the period prior to SIV 277 
infection up to 3 days thereafter when biomarker levels were still unaffected by the 278 
treatment (see Results). We examined whether the acute phase proteins (CRP and HPT) in 279 
the Study 2 animals increased in response to surgical trauma by comparing urinary and fecal 280 
CRP and HPT concentrations in the period within 6 days before versus 6 days after the 281 
surgery for lymph node extirpation using the Wilcoxon signed rank test (due to the small 282 
sample size). 283 
Probability values < 0.05 were considered statistically significant. As our aim was to 284 
discover whether markers were measurable and potentially useful and informative in 285 
different matrices, we considered our analyses exploratory rather than definitive and did 286 
not correct for multiple testing. 287 
288 
289 
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Results 290 
Study 1 291 
Concentrations of all markers in each matrix are presented in Table 1. Values for the 3 long-292 
tailed macaques fell within the range of those of the rhesus macaques. There were no sex 293 
differences in serum levels for any of the three immune markers when analyzed using GLMs 294 
also containing age as a variable (NEO: F1,25 = 0.094, p = 0.763; CRP: F1,24=0.027, p=0.871; 295 
HPT: F1,25=0.179, p=0.676). While we found no effects of age on serum concentrations when 296 
corrected for sex using GLMs (NEO, F1,25=3.297, p=0.082; CRP, F1,24=1.167, p=0.292; HPT, 297 
F1,25=0.473, p=0.498), Spearman’s rank correlations showed significant correlations for NEO 298 
(rs=0.513, n=26, p=0.007) and CRP (rs=0.498, n=26, p=0.010), with older individuals having 299 
higher concentrations of both markers. 300 
301 
Serum–urinary and serum–fecal correlations 302 
Neopterin: Serum NEO concentrations were strongly and significantly correlated with 303 
urinary (rs=0.664, n=27, p<0.001; Fig. 1) but not fecal (rs =0.171, n=27, p=0.196) 304 
concentrations. 305 
CRP: Serum CRP concentrations were not correlated with either urinary (rs = -0.037, n=26, 306 
p=0.429) or fecal CRP measures (rs= -0.003, n=27, p=0.493). 307 
Haptoglobin: Serum and urinary HPT concentrations were not correlated (r=0.264, n=26, 308 
p=0.096). HPT levels in fecal samples were either low or below the detection limit of the 309 
assay. 310 
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Study 2 311 
Generally, for the 3 males and 3 females used in this study baseline values of all three 312 
immune markers (calculated for the period pre-treatment up to 3 days after infection) in 313 
both urine and feces (Table 2) were in the same range exhibited by the healthy animals of 314 
study 1. 315 
Neopterin: Consistent with prior studies, urinary NEO showed a strong response to SIV 316 
infection (Figure 2). Values began to elevate from around one week post-infection, and 317 
typically rose to around 10-25 times baseline levels around day 15 which coincided with 318 
peak viremia. NEO concentrations typically remained elevated for several weeks, though 319 
concentrations greater than 10 times baseline were only seen for around a week. Small 320 
spikes in fecal values around this time were inconsistent in their duration and timing. Given 321 
the vast differences in concentration of NEO detected in feces vs urine (peak levels per ml 322 
urine are about 100 fold higher than baseline fecal levels per g feces; data not shown) , this 323 
is likely due to occasional small (drop-sized) contamination of fecal samples with urine. 324 
CRP: Urinary and fecal CRP excretion patterns showed rises and falls in concentrations that 325 
were not obviously related to the timing of the SIV infection event (Figure 2). In the majority 326 
of animals (4/6) there was on average however an approximately 2.5 fold elevation in CRP 327 
levels in both urine and feces in the days immediately following lymph node 328 
extirpation/intestinal biopsy sampling compared to the days prior to surgery (Figures 3 and 329 
5). Although this elevation was short-lived, lasting for a couple of days at most (see Figure 330 
3), it nonetheless represented a statistically significant increase in both matrices (Figure 5; 331 
urine: z = 1.992, p = 0.023; feces: z = 1.887, p = 0.030). 332 
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 Haptoglobin: Urinary and fecal HPT excretion usually remained consistently low throughout 333 
most of the experimental period. In the majority of animals (5/6) however, an increase was 334 
recorded in levels of urinary HPT in the periods following first bone marrow aspiration, and 335 
in particular in response to the surgery for lymph node extirpation/intestinal biopsy 336 
sampling (Figures 4 and 5). As for CRP, the elevation in levels following surgery was short-337 
lived but statistically significant (z = 1.739, p = 0.037). The rise in HPT levels following lymph 338 
node extirpation/intestinal biopsy sampling was also recorded in fecal samples where it was 339 
much more marked though (Figure 5; z= 2.201, p = 0.014). 340 
341 
Discussion 342 
Our study sought to assess whether several markers of health and immune activity could be 343 
measured non-invasively in non-human primates, and to see how these responded to 344 
medical intervention and infection. Our results demonstrate that it is possible to do this 345 
reliably, and provide baseline data on values of these markers in blood, urine and feces for 346 
visually healthy captive macaques. Our data also show a significant positive correlation 347 
between blood and urinary concentrations of neopterin, further highlighting its potential as 348 
non-invasive markers of changes in circulating blood concentrations. Moreover, consistent 349 
with studies in the pathology literature, tracking of individuals through medical 350 
interventions and following SIV infection shows urinary neopterin to be a highly reliable 351 
marker of infection, with a 10-25 fold increase in excretion in response to SIV infection. 352 
Urinary and fecal levels of the two acute phase proteins did not correlate significantly with 353 
serum values, suggesting that they may be of limited applicability for assessing lower level 354 
inflammation. However, our data do suggest that urinary and fecal CRP and (especially) 355 
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haptoglobin may nevertheless be useful non-invasive markers of inflammation given their 356 
significant, although short-lived, elevation in response to surgical tissue trauma. 357 
Urinary neopterin concentrations correlate positively and significantly with those 358 
found in serum (Figure 1), and respond consistently to SIV infection (Figure 2), a finding in 359 
line with earlier studies (Fendrich et al., 1989; Stahl-Hennig, 2002). Measurement of this 360 
marker in urine from free-ranging macaques is likely to reveal the presence of infections 361 
associated with macrophage activation and the Th 1 response, which promote cellular 362 
immunity in response to intracellular pathogens (e.g bacteria, viruses, fungi or parasites; 363 
Elenkov and Chrousos, 1999). Regular measurement might allow the development of such 364 
an infection to be tracked.  Though this requires regular sampling, such sampling regimes 365 
are a common requirement for other markers too. For example, the tracking of ovulation 366 
through the measurement of estrogen and progestogen metabolites excreted in feces 367 
and/or urine also requires frequent sampling (Hodges and Heistermann 2011). Studies of 368 
free-ranging primates often assess the onset of the luteal phase of the cycle through the 369 
detection of increased progestogen concentrations greater than 2 SDs above the previous 3-370 
5 baseline (follicular phase) values, and maintained for at least 3 consecutive samples 371 
(following Jeffcoate 1983). Similar assessment criteria might be used for urinary neopterin 372 
to determine whether an infection has occurred. 373 
Although fecal neopterin concentrations did not correlate with serum or urinary 374 
concentrations in our study and, in contrast to urinary neopterin, did not show a consistent 375 
response to SIV infection, they are sometimes used not as a general method for measuring 376 
infection in the body, but specifically as a measure of inflammatory gut disease and 377 
infections in humans (Ledjeff et al., 2001; Campbell et al., 2004; Husain et al., 2013). It still 378 
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therefore retains potential as a method of testing for intestinal macrophage activity in non-379 
human primates. Data are required in which fecal neopterin concentrations can be 380 
compared for healthy individuals and individuals known to have inflammatory gut infections 381 
(e.g. see Husain et al. 2013 for humans), or on the same individuals from periods of both gut 382 
infection and health. 383 
Urinary and fecal measures did not correlate with serum values for either CRP or 384 
haptoglobin. It is worth considering that we might expect correlations between 385 
concentrations of analytes in blood and urine rather than in feces. Both blood and urine 386 
concentrations represent relatively short-term measures, with excretion times usually much 387 
quicker for urine than feces (Hodges and Heistermann, 2011), making it more likely that the 388 
former would correlate with measures in blood. In contrast, concentrations in fecal samples 389 
represent the integration of circulating levels over longer periods, and so may not 390 
necessarily be expected to correlate with levels found in blood when analyzing cross-391 
sectional data. Hence, the lack of a correlation between fecal (as well as urinary) and serum 392 
CRP and haptoglobin levels might reflect the rapid and extreme changes in this acute phase 393 
protein during a response which renders it highly unlikely that a snapshot measure such as 394 
serum values corresponds to more long-term measures (see also Touma and Palme, 2005). 395 
It is important also to remember that our sample size in Study 1 of 27 animals is relatively 396 
small, and as all animals were healthy, this might have reduced variation in the dataset 397 
hindering our ability to detect significant correlations. Standardization for creatinine may 398 
also add variation to urinary measures given differences in weight of our study animals 399 
(Crockett et al. 1993). That said, known relationships such as that between serum and 400 
urinary NEO were clearly demonstrated using our sample, indicating that our power was 401 
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sufficient to find such relationships where they exist and are strong. In general though, it is 402 
also worth remembering that in humans these markers are also measured in feces and urine 403 
rather than blood despite the easy availability of the latter specifically because fecal and 404 
urinary measurements are indicative of disease and infection in tissues associated with 405 
excretion pathways, such as the kidneys and the gut, rather than of general systemic 406 
infection. It may therefore be no surprise that correlations between serum, urine and fecal 407 
measures were not found. 408 
Although urinary haptoglobin concentrations did not correlate with those in serum, 409 
the potential usefulness of urinary haptoglobin measurements for monitoring inflammatory 410 
processes is nonetheless suggested by our finding of markedly elevated levels in response to 411 
bone marrow aspiration and lymph node extirpation. In particular, the surgery for lymph 412 
node extirpation is likely to have resulted in tissue trauma, which is known to stimulate an 413 
increase in acute phase protein secretion (Yamamoto et al. 1993; Michelsen et al. 2012). 414 
Haptoglobin concentrations in blood increase in response to infections associated with 415 
inflammation, but typically show a broader and less acute response curve when compared 416 
to other acute phase proteins such as CRP (Gabay and Kushner, 1999). Regular 417 
measurements of urinary haptoglobin might therefore potentially allow inflammatory 418 
infections to be detected and monitored in wild mammals, particularly as haptoglobin 419 
shows a relatively long release function in response to infection (Gabay and Kushner, 1999). 420 
Fecal haptoglobin levels showed a similar response to surgery, with elevations even 421 
more pronounced than those found in urine. Some limited evidence also emerged from 422 
animals of study 1 to suggest that high levels of fecal haptoglobin excretion may be 423 
indicative of health issues. Within the cohort of healthy individuals in three animals ≥15 424 
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times higher concentrations were found compared with the rest of the animals, with one 425 
animal showing an extreme value of >10,000 ng/g (~200 fold elevation above average). 426 
Interviewing the animal keepers and the vet and looking at animal history reports revealed 427 
that in the past these three animals have exhibited symptoms of gut problems, such as 428 
diarrhea or Giardia infection, relatively often. The individual with the highest fecal 429 
haptoglobin level also showed markedly elevated concentrations in fecal and serum CRP 430 
(both 5-fold above the study sample mean) and serum and urinary neopterin (3-fold and 2-431 
fold above the mean, respectively) as well as serum haptoglobin (2 fold above the mean). 432 
This animal was the individual confirmed to be suffering from severe diarrhea and weight 433 
loss during the time of sample collection (see Methods). Information on the gut status of 434 
the two other animals with elevated haptoglobin levels in feces was not available, but 435 
visually they appeared to be healthy (e.g. no diarrhea) when samples were collected. Taken 436 
together, our results are tentative but promising, and suggest that measurement of 437 
haptoglobin in urine and, in particular, feces may have potential for tracking both more 438 
systemic as well as local inflammatory processes in macaques non-invasively. Since the 439 
responses found were short-lived (lasting a few days at most), frequent sampling would be 440 
necessary to detect acute occurrences of inflammation reliably. 441 
Similarly to haptoglobin, we found elevated urinary and fecal CRP concentrations in 442 
response to the surgical tissue trauma associated with lymph node extirpation. This also 443 
suggests that non-invasive measure of CRP may be of potential value for tracking 444 
inflammation in macaques. In contrast to haptoglobin however, CRP excretion patterns 445 
were overall more variable, and the rise in fecal CRP in response to surgery was markedly 446 
weaker than that for haptoglobin. 447 
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Before further studies seek to utilize these or any other markers, it will also be 448 
important to investigate their stability under conditions of contamination with dirt or (in the 449 
case of urine) feces, as well as issues related to how they must be stored and transported. 450 
When careful analyses of such issues are undertaken, detailed recommendations can then 451 
be made to fieldworkers on how to collect, store and transport samples for analysis in a way 452 
that minimizes analyte contamination and degradation (see Higham et al., 2011b for 453 
macaque C-peptides). In addition to urinary and fecal markers, some studies may also wish 454 
to consider measuring relevant analytes from saliva. Methods for saliva collection from 455 
primates have been used in free-ranging settings (Higham et al., 2010), and similar or 456 
adapted methods are probably feasible for numerous (though clearly not all) primate 457 
species in free-ranging populations. In saliva, many native analytes can be measured, 458 
including sympathetic axis correlates such as alpha-amylase (e.g. rhesus macaques, Higham 459 
et al., 2010; bonobos, Beringer et al., 2012), haptoglobin (e.g. pigs, Gómez-Laguna et al., 460 
2010) and CRP (e.g. humans, Rao et al., 2010). 461 
There have been several recent and exciting developments in evolutionary studies of 462 
primate immune function, including publications showing that high-ranking baboon males 463 
heal faster than low-ranking males (Archie et al., 2012), and that rhesus macaque females 464 
experimentally assigned low ranks show increased immune marker and receptor gene 465 
expression (Tung et al., 2012). Hopefully, our study will encourage further investigations of 466 
the non-invasive measurement of immune function. As methods that enable multiple 467 
measurement of many analytes from the same sample become more reliable and 468 
widespread (e.g. Hauser et al., 2011; Weltring et al., 2012), the direct measurement of 469 
multiple markers may hopefully become more common-place. Multi-assays are now 470 
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available that simultaneously measure up to 20 different cytokines and chemokines in non-471 
human primate blood samples (Giavedoni, 2005). Such methods offer great promise, 472 
particularly if they can be applied to non-invasive samples such as urine. We therefore 473 
encourage further evaluations and validations of non-invasive markers in the area of 474 
immune activation and primate health. The development and validation of more non-475 
invasive immune markers is likely to expand our ability to investigate primate behavior, 476 
ecology and evolution considerably. Such measures will prove crucial to establishing the 477 
physiological links connecting variation in behavioral strategies to long-term life-history 478 
outcomes such as mortality, so linking the “short-term behavioral study” and “long-term 479 
demographic study” elements of primatology. 480 
481 
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Figure Legends 704 
Figure 1. The relationship between values of serum and urinary neopterin. 705 
Figure 2. Patterns of urinary and fecal concentrations of neopterin (NEO) in the 6 animals 706 
infected with SIV.  Note the different scales. 707 
Figure 3. Patterns of urinary and fecal excretion of C-reactive protein (CRP) in the 6 animals 708 
infected with SIV. Arrows 1-3 indicate the date of SIV infection (1), first bone marrow 709 
aspiration (2) and surgery for lymph node extirpation combined with second bone marrow 710 
aspiration and colon biopsy (3). Note the different scales. 711 
Figure 4. Patterns of urinary and fecal excretion of haptoglobin (HPT) in the 6 animals 712 
infected with SIV. Arrows 1-3 indicate the timing of SIV infection (1), first bone marrow 713 
aspiration (2) and surgery for lymph node extirpation combined with second bone marrow 714 
aspiration and colon biopsy (3). Note the different scales. 715 
Figure 5. Concentrations of (A) urinary and fecal C-reactive protein (CRP) and (B) urinary and 716 
fecal haptoglobin (HPT) in samples collected within 6 days before and 6 days after surgery 717 
for lymph node extirpation/intestinal biopsy sampling. Bars represent mean + SEM values. 718 
Differences were statistically significant in all cases (see text). 719 
720 
721 
722 
723 
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Table 1. Concentrations of markers measured in Study 1, from 23 rhesus macaques and 3 long-
tailed macaques (age 7.4 ±0.5 (SEM) years, range = 3-11 ys). Body weights were 7.6±0.4 kg 
(range = 4.6–11.7 kg), and BMIs were 27.4± 1.1 (range = 20.8–45.0). 
Marker Matrix Mean SEM Range 
NEO Serum Males 1.4 0.2 0.6-3.1 
Females 2.0 0.2 1.5-2.8 
All 1.6 0.1 0.6-3.1 
Urine Males 171.9 16.0 84.0-366.7 
Females 185.4 26.0 92.9-265.6 
All 175.0 13.6 84.0-366.7 
Feces Males 46.9 7.6 19.3-145.3 
Females 58.4 19.7 21.0-145.8 
All 49.6 7.3 19.3-145.8 
CRP Serum Males 4.7 1.2 1.2-26.3 
Females 6.5 2.1 1.5-13.0 
All 5.1 1.0 1.2-26.3 
Urine Males 22.4 6.8 1.0-94.3 
Females 63.8 34.5 5.2-220.0 
All 32.3 10.0 1.0-220.0 
Feces Males 123.1 31.1 31.0-604.2 
Females 74.6 12.9 36.9-152.8 
All 111.9 24.4 31.0-604.2 
HPT Serum Males 816.0 74.0 170-1260 
Females 641.7 150.4 190-1100 
All 775.8 66.9 170-1260 
Urine Males 37.9 7.0 8.9-102.4 
Females 258.0 143.8 22.3-935.7 
All 90.7 37.8 8.9-935.7 
Feces Not measureable in most samples from healthy individuals. 
Serum concentrations are given in ng/ml (NEO) or µg/ml (CRP and haptoglobin) 
All urinary concentrations are given as ng/mg Cr 
All fecal concentrations are given as ng/g dry weight 
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Table 2. Baseline concentrations of biomarkers and ranges of peak-to-baseline (P/B) ratios 
measured in Study 2 animals  
Marker Matrix Mean ± SEM Range P/B-ratio
NEO Urine Males 145.8 ± 30.1 16.7-25.8 
Females 171.6 ± 13.7 10.8-26.7 
All 158.7 ± 15.9 10.8-26.7 
Feces Males 74.4 ± 4.9 n.a. 
Females 53.2 ± 4.8 n.a. 
All 63.8 ± 5.6 n.a. 
CRP Urine Males 30.8 ± 15.5 1.8-23.3 
Females 47.7 ± 21.4 3.1-6.5 
All 39.3 ± 12.4 1.8-23.3 
Feces Males 123.6 ± 4.0 5.7-14.2 
Females 102.2 ± 21.8 1.3-6.4 
All 112.9 ± 11.0 1.3-14.2 
HPT Urine Males 35.7 ± 2.1 3.2-16.0 
Females 74.6 ± 20.3 2.3-43.1 
All 55.1 ± 12.6 2.3-43.1 
Feces Males 221.4 ± 105.4 11.7-74.6 
Females 103.0 ± 19.7 16.2-105.7 
All 162.2 ± 54.8 11.7-105.7 
n.a. = not applicable (see Results) 
All urinary concentrations are given as ng/mg Cr 
All fecal concentrations are given as ng/g dry weight 
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